However, in other study was shown that GSTM1 and GSTT1 were not associated with the risk of CML, while the variant of the rs1695 polymorphism in the GSTP1 gene may enhance the risk of this disease [64]. The gene discussed is GSTM1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.